Maria Wendt
About
In The Last Decade
Maria Wendt
36 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Physiology 1.3k
- Molecular Biology 749
- Cardiology and Cardiovascular Medicine 735
- Biochemistry 473
- Immunology 393
Countries citing papers authored by Maria Wendt
This map shows the geographic impact of Maria Wendt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Wendt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Wendt more than expected).
Fields of papers citing papers by Maria Wendt
This network shows the impact of papers produced by Maria Wendt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Wendt. The network helps show where Maria Wendt may publish in the future.
Co-authorship network of co-authors of Maria Wendt
This figure shows the co-authorship network connecting the top 25 collaborators of Maria Wendt. A scholar is included among the top collaborators of Maria Wendt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Wendt. Maria Wendt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 0 | |
| 3 | 9 | |
| 4 | 2 | |
| 5 | 0 | |
| 6 | Effects of amitriptyline, fluoxetine, tranylcypromine and venlafaxine on rat vascular smooth muscle in vitro--the role of the endothelium. | 18 |
| 7 | Elimination of PRRS virus (EU-type) from a farrow-to-finish breeding farm by vaccination with Ingelvac® PRRS MLV under unfavourable conditions. | 1 |
| 8 | 52 | |
| 9 | 55 | |
| 10 | 108 | |
| 11 | 236 | |
| 12 | 147 | |
| 13 | 128 | |
| 14 | 42 | |
| 15 | 159 | |
| 16 | 30 | |
| 17 | Effects of Angiotensin II Infusion on the Expression and Function of NAD(P)H Oxidase and Components of Nitric Oxide/cGMP Signaling breakdown → | 561 |
| 18 | 57 | |
| 19 | 55 | |
| 20 | 5 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.